drugset / Trial / NCT00476918

Intravitreal Triamcinolone Acetonide for Diabetic Macular Edema

NCT00476918

Phase 1 Unknown 60 enrolled Heidelberg University
RandomizedSingle-groupDouble-blindTreatment

Summary

Efficacy duration of triamcinolone acetonide (steroid) for treatment of diabetic macular edema. Furthermore, dosage dependency of triamcinolone acetonide comparing a high dosage versus a low dosage.

Timeline

Start
2006-07
Primary completion
Completion
2007-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Triamcinolone Acetonide Other / unclassified Intravitreal